Sanofi
Amgen Inc.
Abott
GlaxoSmithKline PLC
Novartis AG
Astellas Pharma Inc.
Pfizer Inc.
AstraZeneca PLC
Biogen
Johnson & Johnson Services Inc.
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
Merck & Co. Inc.
F. Hoffmann-La Roche AG
Bayer AG
Eli Lilly and Company
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Autoimmune Treatment Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Autoimmune Treatment Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Autoimmune Treatment Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Autoimmune Treatment Market-Segmentation by Type
5.1 Drugs
5.2 Diagnostic Equipment
5.3 Therapeutic and Monitoring Equipment
6 Global Autoimmune Treatment Market-Segmentation by Application
6.1 Hospitals
6.2 Clinics
6.3 Drug Stores
6.4 Independent pharmacies
6.5 Others
7 Global Autoimmune Treatment Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Sanofi
8.1.1 Sanofi Profile
8.1.2 Sanofi Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Sanofi Product/Solution Launches and Enhancements Analysis
8.1.4 Sanofi Business Overview/Recent Development/Acquisitions
8.2 Amgen Inc.
8.2.1 Amgen Inc. Profile
8.2.2 Amgen Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Amgen Inc. Product/Solution Launches and Enhancements Analysis
8.2.4 Amgen Inc. Business Overview/Recent Development/Acquisitions
8.3 Abott
8.3.1 Abott Profile
8.3.2 Abott Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Abott Product/Solution Launches and Enhancements Analysis
8.3.4 Abott Business Overview/Recent Development/Acquisitions
8.4 GlaxoSmithKline PLC
8.4.1 GlaxoSmithKline PLC Profile
8.4.2 GlaxoSmithKline PLC Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 GlaxoSmithKline PLC Product/Solution Launches and Enhancements Analysis
8.4.4 GlaxoSmithKline PLC Business Overview/Recent Development/Acquisitions
8.5 Novartis AG
8.5.1 Novartis AG Profile
8.5.2 Novartis AG Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Novartis AG Product/Solution Launches and Enhancements Analysis
8.5.4 Novartis AG Business Overview/Recent Development/Acquisitions
8.6 Astellas Pharma Inc.
8.6.1 Astellas Pharma Inc. Profile
8.6.2 Astellas Pharma Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Astellas Pharma Inc. Product/Solution Launches and Enhancements Analysis
8.6.4 Astellas Pharma Inc. Business Overview/Recent Development/Acquisitions
8.7 Pfizer Inc.
8.7.1 Pfizer Inc. Profile
8.7.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Pfizer Inc. Product/Solution Launches and Enhancements Analysis
8.7.4 Pfizer Inc. Business Overview/Recent Development/Acquisitions
8.8 AstraZeneca PLC
8.8.1 AstraZeneca PLC Profile
8.8.2 AstraZeneca PLC Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 AstraZeneca PLC Product/Solution Launches and Enhancements Analysis
8.8.4 AstraZeneca PLC Business Overview/Recent Development/Acquisitions
8.9 Biogen
8.9.1 Biogen Profile
8.9.2 Biogen Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Biogen Product/Solution Launches and Enhancements Analysis
8.9.4 Biogen Business Overview/Recent Development/Acquisitions
8.10 Johnson & Johnson Services Inc.
8.10.1 Johnson & Johnson Services Inc. Profile
8.10.2 Johnson & Johnson Services Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Johnson & Johnson Services Inc. Product/Solution Launches and Enhancements Analysis
8.10.4 Johnson & Johnson Services Inc. Business Overview/Recent Development/Acquisitions
8.11 Bristol-Myers Squibb Company
8.11.1 Bristol-Myers Squibb Company Profile
8.11.2 Bristol-Myers Squibb Company Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Bristol-Myers Squibb Company Product/Solution Launches and Enhancements Analysis
8.11.4 Bristol-Myers Squibb Company Business Overview/Recent Development/Acquisitions
8.12 Boehringer Ingelheim GmbH
8.12.1 Boehringer Ingelheim GmbH Profile
8.12.2 Boehringer Ingelheim GmbH Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Boehringer Ingelheim GmbH Product/Solution Launches and Enhancements Analysis
8.12.4 Boehringer Ingelheim GmbH Business Overview/Recent Development/Acquisitions
8.13 Merck & Co. Inc.
8.13.1 Merck & Co. Inc. Profile
8.13.2 Merck & Co. Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Merck & Co. Inc. Product/Solution Launches and Enhancements Analysis
8.13.4 Merck & Co. Inc. Business Overview/Recent Development/Acquisitions
8.14 F. Hoffmann-La Roche AG
8.14.1 F. Hoffmann-La Roche AG Profile
8.14.2 F. Hoffmann-La Roche AG Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 F. Hoffmann-La Roche AG Product/Solution Launches and Enhancements Analysis
8.14.4 F. Hoffmann-La Roche AG Business Overview/Recent Development/Acquisitions
8.15 Bayer AG
8.15.1 Bayer AG Profile
8.15.2 Bayer AG Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Bayer AG Product/Solution Launches and Enhancements Analysis
8.15.4 Bayer AG Business Overview/Recent Development/Acquisitions
8.16 Eli Lilly and Company
8.16.1 Eli Lilly and Company Profile
8.16.2 Eli Lilly and Company Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 Eli Lilly and Company Product/Solution Launches and Enhancements Analysis
8.16.4 Eli Lilly and Company Business Overview/Recent Development/Acquisitions
9 Global Autoimmune Treatment Market-Segmentation by Geography
10 North America
10.1 North America Autoimmune Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Autoimmune Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Autoimmune Treatment Production Analysis from 2015-2020
10.4 North America Autoimmune Treatment Consumption Analysis from 2015-2020
10.5 North America Autoimmune Treatment Import and Export from 2015-2020
10.6 North America Autoimmune Treatment Value, Production and Market Share by Type (2015-2020)
10.7 North America Autoimmune Treatment Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Autoimmune Treatment by Country (United States, Canada)
10.8.1 North America Autoimmune Treatment Sales by Country (2015-2020)
10.8.2 North America Autoimmune Treatment Consumption Value by Country (2015-2020)
10.9 North America Autoimmune Treatment Market PEST Analysis
11 Europe
11.1 Europe Autoimmune Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Autoimmune Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Autoimmune Treatment Production Analysis from 2015-2020
11.4 Europe Autoimmune Treatment Consumption Analysis from 2015-2020
11.5 Europe Autoimmune Treatment Import and Export from 2015-2020
11.6 Europe Autoimmune Treatment Value, Production and Market Share by Type (2015-2020)
11.7 Europe Autoimmune Treatment Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Autoimmune Treatment by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Autoimmune Treatment Sales by Country (2015-2020)
11.8.2 Europe Autoimmune Treatment Consumption Value by Country (2015-2020)
11.9 Europe Autoimmune Treatment Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Autoimmune Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Autoimmune Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Autoimmune Treatment Production Analysis from 2015-2020
12.4 Asia-Pacific Autoimmune Treatment Consumption Analysis from 2015-2020
12.5 Asia-Pacific Autoimmune Treatment Import and Export from 2015-2020
12.6 Asia-Pacific Autoimmune Treatment Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Autoimmune Treatment Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Autoimmune Treatment by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Autoimmune Treatment Sales by Country (2015-2020)
12.8.2 Asia-Pacific Autoimmune Treatment Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Autoimmune Treatment Market PEST Analysis
13 Latin America
13.1 Latin America Autoimmune Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Autoimmune Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Autoimmune Treatment Production Analysis from 2015-2020
13.4 Latin America Autoimmune Treatment Consumption Analysis from 2015-2020
13.5 Latin America Autoimmune Treatment Import and Export from 2015-2020
13.6 Latin America Autoimmune Treatment Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Autoimmune Treatment Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Autoimmune Treatment by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Autoimmune Treatment Sales by Country (2015-2020)
13.8.2 Latin America Autoimmune Treatment Consumption Value by Country (2015-2020)
13.9 Latin America Autoimmune Treatment Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Autoimmune Treatment Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Autoimmune Treatment Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Autoimmune Treatment Production Analysis from 2015-2020
14.4 Middle East & Africa Autoimmune Treatment Consumption Analysis from 2015-2020
14.5 Middle East & Africa Autoimmune Treatment Import and Export from 2015-2020
14.6 Middle East & Africa Autoimmune Treatment Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Autoimmune Treatment Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Autoimmune Treatment by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Autoimmune Treatment Sales by Country (2015-2020)
14.8.2 Middle East & Africa Autoimmune Treatment Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Autoimmune Treatment Market PEST Analysis
15 Future Forecast of the Global Autoimmune Treatment Market from 2020-2028
15.1 Future Forecast of the Global Autoimmune Treatment Market from 2020-2028 Segment by Region
15.2 Global Autoimmune Treatment Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Autoimmune Treatment Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
